Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques

Rationale: Direct evidence for persistence of Mycobacterium tuberculosis (Mtb) during asymptomatic latent tuberculosis infection (LTBI) in humans is currently lacking. Moreover, although a 12-week regimen of once-weekly isoniazid and rifapentine (3HP) is currently recommended by the CDC as treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Respir Crit Care Med
Main Authors: Foreman, Taylor W., Bucşan, Allison N., Mehra, Smriti, Peloquin, Charles, Doyle, Lara A., Russell-Lodrigue, Kasi, Gandhi, Neel R., Altman, John, Day, Cheryl L., Ernst, Joel D., Blumberg, Henry M., Rengarajan, Jyothi
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049922/
https://ncbi.nlm.nih.gov/pubmed/31647877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201903-0646OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados